Organon (OGN) Operating Margin Growth (3y) (2023 - 2026)
Organon (OGN) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.95 Bn | 632.19 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 469.97 Bn | 463.40 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 377.05 Bn | 369.90 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 302.66 Bn | 294.97 Bn | 11.24 Bn | 842.00 |
| 5 | Astrazeneca | 258.09 Bn | 253.19 Bn | 12.86 Bn | -95.00 |
| 6 | Amgen | 236.99 Bn | 223.00 Bn | 7.24 Bn | -347.00 |
| 7 | Gilead Sciences | 183.08 Bn | 179.90 Bn | 6.22 Bn | -15,844.00 |
| 8 | Pfizer | 160.54 Bn | 148.84 Bn | 10.94 Bn | 20,333.00 |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn | -2,411.00 |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | -346.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,474.00 |
| Mar 31, 2026 | 3,853.00 |
| Dec 31, 2025 | 4,646.00 |
| Sep 30, 2025 | 3,985.00 |
| Jun 30, 2025 | 3,932.00 |
| Mar 31, 2025 | 2,339.00 |
| Dec 31, 2024 | 4,074.00 |
| Sep 30, 2024 | 3,973.00 |
| Jun 30, 2024 | 3,317.00 |
| Mar 31, 2024 | -1,822.00 |
| Dec 31, 2023 | -3,245.00 |
| Sep 30, 2023 | -4,407.00 |
| Jun 30, 2023 | -3,986.00 |
| Mar 31, 2023 | -3,962.00 |